Fredun Pharmaceuticals fundamental analysis
FREDUN
1664.2
48.05 (-2.81%)Last updated on 20 Feb, 2026 | 15:42 IST
BUYSELL
Free Demat with Zero AMC*
Fredun Pharmaceuticals Fundamentals
P/E Ratio
27.33
P/B Ratio
3.6
Div. Yield
0.04
Sector P/E
63.23
Sector P/B
2.76
Sec. Div. Yield
0.57
Fredun Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 27.33, compared to the sector average of 63.23. Its P/B Ratio stands at 3.6, while the sector’s is 2.76. In terms of returns, the stock offers a Dividend Yield of 0.04%, which is than the sector’s 0.57%.
Fredun Pharmaceuticals Score Card
Price
Attractive
Growth
Good
Quality
Poor
Management
Good
On its scorecard, Fredun Pharmaceuticals reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
Fredun Pharmaceuticals Associated Pages
- Fredun Pharmaceuticals Share Price
- Fredun Pharmaceuticals Share Price chart
- Fredun Pharmaceuticals Technical Analysis
- Fredun Pharmaceuticals Peer Comparison
- Fredun Pharmaceuticals Share Price History
- Fredun Pharmaceuticals Dividend
- Fredun Pharmaceuticals Board of Directors
- Fredun Pharmaceuticals Shareholding Pattern
